AIM Vaccine Receives CDE Approval for Serum-Free Rabies Vaccine Trial
China-based AIM Vaccine Co., Ltd (HKG: 6660) has announced receiving clinical trial approval from the...
AIM Vaccine
AIM Vaccine Plans IPO to Fund Vaccine R&D and Pipeline Expansion
China-based AIM Vaccine Co., Ltd plans to make an initial public offering (IPO) of 9.71...